CBAY - CymaBay Therapeutics stock gains after CEO buys shares worth $100K
CymaBay Therapeutics (NASDAQ:CBAY) stock edge higher after disclosing that its CEO Sujal Shah bought 51.301K shares of common stock on 6 June. As per regulatory filing, shares were purchased at $1.95, for total transaction size of $100K.
For further details see:
CymaBay Therapeutics stock gains after CEO buys shares worth $100K